Background Nonthoracotomy-implantable cardioverter/defibrillator (ICD) systems may represent a significant advance in the treatment of patients with life-threatening ventricular arrhythmias, but their merits relative to those of the wellestablished thoracotomy systems remain largely unknown. The objective of this study was to compare the short-and long-term clinical outcomes after attempted ICD implantation via a nonthoracotomy versus thoracotomy approach in similar groups of patients.
Methods and Results Between September 1990 and December 1992, 212 consecutive patients underwent attempted ICD system implantation without concomitant cardiac surgery at a single institution. Approach selection was not randomized but rather was based primarily on hardware availability. Primary comparisons of short-and long-term outcome were performed according to the "intention-to-treat" principle. Implantation was attempted via a nonthoracotomy approach in 120 patients (57%) and via a thoracotomy approach in 92 patients (43%). Prior cardiac surgery was more prevalent in the nonthoracotomy patients; otherwise, groups did not differ significantly in terms of prognostically relevant clinical characteristics. Nonthoracotomy implantation was successful in 101 patients (84%). After crossover to thoracotomy implantation (14 patients), the eventual success rate for ICD system implantation was 96% in the nonthoracotomy group. Thoracotomy implan-T he implantable cardioverter/defibrillator (ICD) has dramatically reduced the incidence of sudden cardiac death in patients with life-threatening ventricular tachyarrhythmias.1-3 Since its initial clinical use in 1980,4 ICD system technology has evolved significantly. New tiered-therapy ICDs not only are capable of defibrillation but also can provide low-energy cardioversion and antitachycardia and antibradycardia pacing.5-8 The lead systems used in interfacing the generator to the heart have evolved similarly. Early experiences with nonthoracotomy defibrillating lead systems9, 10 were fraught with problems of poor lead reliability,11 but continued research and development in this area resulted in the availability of several promising nonthoracotomy lead systems for clinical application.12-15 It has been suggested that, compared with the conventional thoracotomy approach, the emerging nonthoracotomy lead technology decreases operative morbidity and mortality16-18 without compromising the long-term efficacy of defibrillator therapy. However, the relative merits of the two approaches have not been assessed in a large series of consecutive patients. In this study, we compare the short-and long-term clinical results of ICD systems implanted via a nonthoracotomy or a thoracotomy approach in similar groups of patients using an "intention-to-treat" principle. 19 This pragmatic form of analysis provides the practitioner with information on outcomes that can be readily integrated into the clinical decision-making process.
Methods Patient Population
The study population is composed of 212 consecutive patients who underwent an initial attempt at ICD implantation without concomitant cardiac surgery between September 11, 1990 , and December 31, 1992 Patient Follow-up
Patients were followed up for 16±9 months (mean±SD). Periodic follow-up was conducted at the Cleveland Clinic Foundation in 71% of patients. The remaining patients were followed up by phone contact with them or their physicians. Follow-up was complete in 99.5% of patients through April 15, 1993 . One nonthoracotomy ICD system recipient was lost to follow-up after 26 months and was censored from analysis at time of last contact.
Cost Measurements
Hospital costs for the entire initial admission were downloaded from a commercially available data management system (Transistion Systems, Inc), which consists of a detailed accounting system linked to a computerized database. A "bottom-up"31 approach is used to estimate all costs incurred during a hospital admission. Costs are measured by a combination of "microcosting" techniques, including time-motion studies. Costs are categorized as technical or professional, with each category subdivided into direct and indirect. Direct costs included those directly linked to the production of a given service (defibrillator hardware, disposable supplies, pharmaceuticals). Indirect (overhead) costs included those that cannot be directly traced to a given output (eg, electricity, laundry, maintenance, etc). (43) 46 (38) 45 (49) 11 89 (42) 53 (44) 36 (39) Q09* IlIl 28 (13) 17 (14) 11 (12) (
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Statistical Analysis
All primary analyses were conducted according to the "intention-to-treat" principle. 19 Patients were assigned to the initial approach attempted regardless of success or failure in implanting the ICD system with that approach and regardless of subsequent crossover to the alternative approach or ICD explant. Secondary analyses were performed according to actual treatment received. These analyses differed from the primary "intention-to-treat" analyses in that (1) patients were censored from the initial approach group at time of crossover and were thereafter assigned to the alternative group; (2) patients who did not have an ICD implanted were censored from follow-up after 30 days (to account only for operative morbidity and mortality); and (3) patients who underwent ICD system explantation without system replacement by the end of the study because of infection (1 patient), cardiac transplant (3 patients), or lead fracture secondary to generator "twiddling" with impossibility of regaining access to the central venous system and refusal of thoracotomy (1 patient Table 3 . Significantly lower incidences of postoperative congestive heart failure and supraventricular arrhythmias were observed in the nonthoracotomy group. These differences persisted in the secondary analysis.
In the nonthoracotomy group, 3 of the patients in the pulmonary complications group had small pneumothoraces that did not require intervention. One patient experienced a hemopneumothorax that required transfusion and thoracoscopic evacuation, 2 patients developed pneumonia (1 after crossover to the thoracotomy approach), and 1 patient developed adult respiratory distress syndrome, also after crossover. All 3 required prolonged mechanical ventilatory support. Reoperation, n (%)
28 (23) 19 (21) .74 28 (23) 21 (20) .62 SVT indicates supraventricular tachycardia; VT, ventricular tachycardia.
In the thoracotomy group, 1 of the pulmonary complications was a pneumothorax after subxiphoid access requiring chest tube placement, 3 patients experienced pulmonary embolism, 2 patients developed pneumonia, 2 patients developed sepsis-associated adult respiratory distress syndrome, and 1 patient with severe preexisting lung disease developed ventilatory failure. The latter 5 patients required prolonged mechanical ventilatory support.
Vascular complications in the nonthoracotomy group included the creation of an aorto-innominate fistula during vascular sheath/lead placement in 1 patient; the development of axillary, subclavian, cephalic, and jugular venous thrombosis after a failed nonthoracotomy attempt in 1 patient; and the development of hematomas in 3 patients, all of them on warfarin (1 at the subcutaneous patch site and 2 at the generator site).
Vascular complications in the thoracotomy group included two episodes of postoperative mediastinal bleeding requiring reoperation and repair (in one patient, the circumflex artery had been eroded by the epicardial patch) and the development of lower extremity deep venous thrombosis in 1 patient.
Two patients in the nonthoracotomy group experienced miscellaneous surgical complications. One patient with preexisting complete left bundle branch block developed transient complete heart block during placement of the right ventricular defibrillating/sensing lead and required temporary pacing for 24 hours. One patient developed cutaneous erosion at the generator site without infection that required surgical revision. Miscellaneous surgical complications in the thoracotomy group were more severe. One patient experienced perforation of the right ventricle during epimyocardial lead placement that required emergent median sternotomy for control of bleeding. Two patients suffered postoperative cerebrovascular accidents and 1 patient, a myocardial infarction. Two patients developed sepsis without evidence of ICD infection.
Two of the 3 patients in the nonthoracotomy group who developed ICD system infection required system explantation, which was easily performed without the need for specialized extraction tools, and prolonged parenteral antibiotic therapy for successful management. Both underwent successful ICD system reimplantation after infection was cleared. One patient was managed with long-term antibiotic therapy alone.
Four of the 5 patients in the thoracotomy group who developed ICD infection had deep-seated infection and were managed with system explantation and prolonged parenteral antibiotic therapy. Three of these patients underwent successful ICD system reimplantation. Another patient with a superficial wound infection was successfully managed with a short course of oral antibiotics.
Lead Complications and Reoperations
Lead complications and their remedial actions are presented in Table 4 . Nine patients (8%) in the nonthoracotomy group experienced lead complications. Intracardiac lead or extrathoracic patch migration were responsible for 6 of these. Five patients (5%) in the thoracotomy group experienced lead complications. thoracotomy group were the result of the migration of an epicardial patch. There was no significant difference in the proportion of patients with lead complications in each group (P=.28).
Twenty-eight (23%) of the nonthoracotomy group patients required a total of 31 reoperative procedures during the follow-up period. This includes 16 reoperations for 14 patients undergoing crossover implantation of a thoracotomy system, 7 for lead complications, 3 for vascular/bleeding complications, 1 for generator pocket erosion, and 4 for the management of 2 ICD system infections. Nineteen patients (21%) in the thoracotomy group required a total of 23 reoperative procedures during the follow-up period. This includes 10 "delayed" attempted implants after failure to achieve a working system at initial implant (8 of them successful), 3 related to lead complications, 2 for mediastinal bleeding, and 8 for the management of four ICD system infections (1 patient required 2 operations to reimplant a functioning system, and 1 patient underwent system explantation without reimplant). There was no significant difference in the proportion of patients requiring reoperations in each group (P=.74).
Hospital Costs for the Initial Admission
True hospital costs for the initial admission using the "intention-to-treat" approach are presented in Table 5 . Technical direct costs (composed mainly of the ICD pulse generator and lead system costs) were similar in the two groups. Indirect technical costs, professional costs, and total costs were significantly lower in the nonthoracotomy group. Median total hospital costs were $5420 lower in the nonthoracotomy group. Learning Curve Effect for the
Nonthoracotomy Approach
There were no significant differences in any of the baseline clinical variables between the first and second half of patients in the nonthoracotomy group. Likewise, there were no significant differences in the implant success rate, operative mortality, and incidence of complications. Postoperative hospital stay was significantly shorter for patients in the second half (median, 5 The incidence of pulmonary complications was similar in the two groups, although they tended to be less tomy implant success rate severe in the nonthoracotomy group. In the nonthoraeported. Importantly, the cotomy group, longer anesthesia times and pneumothoonthoracotomy implantaraces may have counterbalanced the avoidance of the racotomy ICD system. In deleterious effects of the thoracotomy on the mechanics fibrillation thresholds did of respiratory function. As in a previous report,4' the rossover. Therefore, the incidence of postoperative ventricular arrhythmias did es were almost identical not depend on the operative approach, suggesting that groups.
the catecholamine responses to surgery may be more important than the direct effects of the myocardial patches in their genesis. It is encouraging that no complication was significantly more frequent in the nonthoracotomy group, allowing for future refinements in lead design and energy delivery to further reduce surgical morbidity with nonthoracotomy ICD implantation. The incidence of ICD system infection did not differ significantly between the two approaches. In all but one case, a combined strategy of system explantation and antibiotic therapy was required for the successful management of infection. However, while the explantation of a thoracotomy ICD system required a major surgical intervention, explantation of nonthoracotomy systems was easily achieved under local anesthesia without the need for specialized lead extraction tools.
Lead Complications
The complex design of multielectrode nonthoracotomy defibrillation leads, their extended subcutaneous course, and the frequent positioning of the subcutaneous patch in a region subject to repetitive movement (ie, axilla) would appear to place these lead systems at a higher risk for dislodgment, migration, and conductor or insulation breakdown. The incidence of lead complications did not differ significantly between patients with nonthoracotomy and thoracotomy systems. With both approaches, the majority of them consisted of transvenous lead or defibrillation patch migration. However, epicardial patch migration was more often associated with preservation of defibrillation capabilities than was nonthoracotomy lead migration, with fewer reoperative procedures required for repair. Thus, the functional integrity of nonthoracotomy ICD systems appears more vulnerable to lead migration than does that of thoracotomy systems.
Our study underscores the frequent need for reoperative procedures in ICD recipients, a point that has not been emphasized previously. With both implant approaches, up to a 15% incidence of failure to achieve a functioning system at the initial implant attempt can be expected. However, the majority of these failures may be remedied with an additional procedure (ie, crossover to thoracotomy implantation or the creation of a "hybrid" system by combining epicardial and nonthoracotomy electrodes). Therefore, teamwork between cardiac electrophysiologists and cardiovascular surgeons is still needed to guarantee optimal defibrillator therapy.
Long-term Survival
The nearly complete prevention of sudden death in both groups reaffirms the efficacy of ICDs in terminating ventricular tachyarrhythmias and confirms the longterm reliability of current nonthoracotomy ICD systems. There were no significant differences in the 1-and 2-year actuarial survival between the two groups. Survival in the thoracotomy group is in agreement with previous reports, but survival in the nonthoracotomy group was poorer. For example, Bardy et al1' reported a 98% survival rate over 11 months and Bocker et al36 a 95% rate over 12 months. In our study, death was most frequently the result of progressive congestive heart failure. Again, differences in patient selection may have contributed to the observed disparities in survival, in view of the unexpectedly low incidence of cardiac ies. Survival in patients with life-threatening ventricular tachyarrhythmias, including those undergoing ICD implantation, depends primarily on the severity of heart failure and left ventricular dysfunction.42-45 Because patients more likely to benefit from ICD therapy have concurrent competing risks of death from heart failure and acute myocardial ischemia, the benefits of ICD therapy on overall survival have been difficult to demonstrate in the absence of randomized trials. 46, 47 
Study Limitations
Because of the lack of randomization, the presence of hidden, subtle selection biases cannot be ruled out. Although there were no statistically significant differences in baseline prognostic variables between the two groups, 3% of the patients in the nonthoracotomy group were in functional class IV, whereas none in the thoracotomy group were in class IV. This could explain the trend toward more frequent incidence of death from heart failure in the nonthoracotomy group. Few patients in the nonthoracotomy group received devices with biphasic waveform capabilities. Early reports suggest that the efficiency of nonthoracotomy defibrillation lead systems can be greatly enhanced by a biphasic waveform. 48 Dislodgment of a coronary sinus lead accounted for 50% of the lead dislodgments in the nonthoracotomy group. Recent reports do not suggest increased defibrillation efficiency for lead configurations including the coronary sinus, and we, like most investigators, have abandoned that practice. Because 100% of the nonthoracotomy systems and 47% of the thoracotomy systems were implanted within clinical research protocols, implantation procedures often required extensive testing to meet protocol criteria. This extensive testing may not reflect the patterns of clinical practice once such systems are available outside investigational protocol. We did not find a learning-curve effect by comparing results in the first versus the second half of the patients with attempted nonthoracotomy implantation. This could be the result of our earlier experience with another nonthoracotomy lead system10 or the use of different nonthoracotomy lead systems that were introduced at different times during the time frame of the study. Alternatively, the learning curve may be very steep, and stable results could have been achieved after few implants.
As a consequence of the relatively recent availability of the nonthoracotomy lead systems for investigational use, the follow-up period is necessarily short. As yet unanswered questions regarding the long-term stability, integrity, and clinical performance of such lead systems will require a longer duration of follow-up to satisfactorily address these issues.
Conclusions
Implantation of ICD systems via a nonthoracotomy approach can be achieved with a high degree of success in unselected patients with life-threatening ventricular tachyarrhythmias. The nonthoracotomy approach is associated with significant advantages with regard to surgical morbidity, hospitalization, and hospital costs compared with the well-established thoracotomy approach. Long-term outcome seems not to be compromised by the nonthoracotomy approach, which confers nonarrhythmic death in the previously mentioned studsimilar protection from sudden cardiac death. There-fore, recommendations by federal regulatory agencies for the conduction of randomized studies comparing thoracotomy versus nonthoracotomy ICD systems do not seem justified. Likewise, current and future trials49,50 evaluating ICD therapy against alternative treatments should endorse nonthoracotomy as the initial approach to ICD implant. We conclude from these nonrandomized data that a nonthoracotomy approach should probably be considered as the procedure of choice for patients requiring ICD implantation without concomitant cardiac surgery. Anticipated advances in energy storage and delivery technology will soon make possible pectoral ICD implantation with a single transvenous lead.51 Therefore, optimistic expectations for improved ICD performance, less invasive implantation with lower morbidity, and further improvement in costeffectiveness52,53 are realistic.
